6:15 PM
 | 
Dec 18, 2012
 |  BC Extra  |  Company News

Shire, Arrowhead partner for peptide-drug conjugates

Shire plc (LSE:SHP; NASDAQ:SHPG) partnered with Arrowhead Research Corp. (NASDAQ:ARWR) to develop and commercialize peptide-drug conjugates using Arrowhead's Homing Peptide technology, which is a library of peptide sequences that localize to specific tissues. Arrowhead will use its technology to identify peptides that selectively target an undisclosed tissue type from Shire, which will provide...

Read the full 252 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >